Inventiva IVA 深 沪
等待开盘 10-16 09:30:00 美东时间
3.13
+0.260
+9.06%
华盛通- 最 高3.15
- 今 开2.95
- 成交量 247.37万股
- 最 低 2.935
- 昨 收 2.87
- 总市值 7.39亿
- 52周最高 7.9825
- 市盈率 静 --
- 换手率 1.05%
- 52周最低 2.82
- 委 比 -12.10%
- 总股本 2.36亿
- 历史最高 19.064
- 量 比 0.97
- 振 幅 7.49%
- 历史最低 1.53
- 每 手 1
- 风险率 0.95%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Inventiva Showcases New Lanifibranor Data as Pan-PPAR MASH Strategy Advances
The latest update is out from Inventiva ( ($FR:IVA) ). Inventiva will present t...
10-07 04:45
美股前瞻 | 美联储10月加息概率已不足25%；台积电盘前涨2%开盘将创新高；高通与华为达成重磅专利协议
加息阴影退去？美联储10月加息概率已不足25%；马斯克拟与台积电推进Terafab合作，台积电涨逾2%开盘将创新高，英特尔大跌4%；高通与华为达成重磅专利协议>>
10-05 20:47
电话会总结 ｜ Inventiva(IVA)2026财年Q2业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 财务业绩：- **现金及短期存款**：截至2026年6月30日，公司持有现金、现金等价物及短期存款合计2.339亿欧元。 - **净亏损**：2026年上半年净亏损为6,950万欧元。 - **研发费用（R&D）**：2026年上半年研发费用为4,620万欧元。 - **一般及行政费用（G&A）**：2026年上半年一般及行政费用为2,220万欧元。 - **市场营销及业务拓展费用**：2026年上半年增加至260万欧元。 - **股权融资**：通过美国存托股份（ADS）公开发行募集总额1.03亿欧元。 - **债务融资**：获得最高1.3亿欧元的分
09-30 10:19
美股大行评级 | 潜在涨幅11184.05%！如瑞迪博士获花旗上调目标价至1450美元，维持"买入"评级
今日重点评级关注：花旗：上调如瑞迪博士"买入"评级，目标价从1040美元升至1450美元；加拿大帝国商业银行：维持Inventiva"买入"评级，目标价从20美元升至21美元
09-30 08:33
Canaccord Genuity Maintains Buy on Inventiva, Raises Price Target to $21
Canaccord Genuity analyst Edward Nash maintains Inventiva (NASDAQ:IVA) with a Buy and raises the price target from $20 to $21.
09-30 00:02
Vail Resorts, Inventiva And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures falling around 0.1% on Tuesday. Shares of Vail Resorts Inc (NYSE:MTN) fell sharply in pre-market trading as the company reported mixed results for the fourth quarter. The company posted quarterly losses of $5.34 per share, which missed...
09-29 20:01
Inventiva S.A reports 1H results
Inventiva S.A press release (IVA): there were no revenues recorded for the first half of 2026, compared to €4.5 million generated for the same period in 2025. The company’s net loss stood at (€69.5) ...
09-28 15:44
Inventiva H1 EPS $(0.29) Misses $(0.20) Estimate, Sales $23.251K Miss $10.000M Estimate
Inventiva (NASDAQ:IVA) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate of $(0.20) by 45 percent. This is a 84.24 percent increase over losses of $(1.84) per share from the same period last year. The company reported quarterly sales of $23.251 thousand which...
09-28 14:11
Earnings Scheduled For September 25, 2026
Companies Reporting Before The Bell • Tamboran Resources (NYSE:TBN) is estimated to report quarterly loss at $0.30 per share on revenue of $3.82 million. Companies Reporting After The Bell • Inventiva (NASDAQ:IVA) is expected to report quarterly loss at $0.20 per share on revenue of $10.00 million. ...
09-25 19:11
Novo Nordisk, Telix Pharmaceuticals And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
U.S. stock futures were higher this morning, with the Nasdaq 100 futures gaining around 1% on Monday. Shares of Novo Nordisk A/S (NYSE:NVO) fell sharply in pre-market trading after the company released topline results from Phase 3 REIMAGINE 5 and REDEFINE 9 trials of once-weekly Cagrisema (Cagrilint...
09-21 20:04
